A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Despite several therapeutic strategies having been developed, cancer is still one of the leading causes of mortality ...
A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart ...
A team of Northwestern investigators has discovered novel molecular underpinnings of a common oncogenic mutation in cancer, ...
Hereditary breast cancer due to genetic mutations accounts for 5% to 10% of breast cancers. Breast cancer is the most ...
What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback